The back-to-office push is meeting stiff resistance from employees, many of whom aren’t complying with existing mandates.

Recursion Pharmaceuticals (RXRX 0.02%), a biotech company focused on artificial intelligence (AI), went public in April 2021. This was before ChatGPT, before AI became the hottest ...

Google's updated documentation asks publishers to change how they use JavaScript to block users from paywalled content.

Recursion Pharma has agreed to merge with rival AI-powered drug discovery firm Exscientia in an all-stock deal valued at $688 million ...

Bulk Rename Utility is a lightweight, easy-to-use file renamer. Effortlessly rename multiple files or folders with flexible options—minimal memory use means it runs quietly in the background.

Find the latest analyst research, reports, and ratings for Recursion Pharmaceuticals, Inc. Class A Common Stock (RXRX) at Nasdaq.com.

View the most recent data and latest information on option chains for Recursion Pharmaceuticals, Inc. Class A Common Stock (RXRX) at Nasdaq.com.